Ishares Msci Brazil ETF vs Roivant Sciences Ltd. Common Shares — how do they compare? Ishares Msci Brazil ETF trades at $43.3 (market cap $11.30B), while Roivant Sciences Ltd. Common Shares trades at $34.49 (market cap $24.72B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 2.2× Ishares Msci Brazil ETF's market cap, and Ishares Msci Brazil ETF is trading nearer its 52-week high, Roivant Sciences Ltd. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ishares Msci Brazil ETF for 50 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.
| EWZ | ROIV | |
|---|---|---|
Market Cap | $11.30B | $24.72B |
Volume | 44,036,597 | 6,279,442 |
Sector | Broad Market / Factor | Health |
52-Week High | $43.00 | $41.81 |
52-Week Low | $28.79 | $16.04 |
Typical Hold Time | 50 Days | 0 Days |
Enterprise Value | — | $20.99B |
Signals from Pluang's Aura AI — not financial advice
EWZ, the iShares MSCI Brazil ETF, trades at $43.14, up 1.82% with strong bullish momentum from moving averages but overbought RSI signals. The ETF shows unusual options activity and institutional interest, driven by Brazil's upcoming election and commodity exposure. Recent news highlights Wall Street positioning for potential policy shifts under different election outcomes, with the fund serving as a diversification tool from U.S. tech concentration.
Outlook remains election-dependent with asymmetric upside potential through call options. Risks include political volatility, U.S.-Brazil trade tensions, and currency fluctuations. The technical setup suggests near-term consolidation near pivot points while fundamentals rely on Brazil's economic policies and commodity performance.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
EWZ is a country-specific ETF that tracks the Brazilian equity market. It provides exposure to large and mid-sized companies in Brazil, with a heavy focus on financials and materials, including major names like Nu Holdings, Vale, and Itaú Unibanco.
Read more on EWZ →Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →